Skip to main content
Erschienen in: Rheumatology International 12/2013

01.12.2013 | Original Article

Characteristics of cerebrovascular accidents at time of diagnosis in a series of 98 patients with giant cell arteritis

verfasst von: Thierry Zenone, Marie Puget

Erschienen in: Rheumatology International | Ausgabe 12/2013

Einloggen, um Zugang zu erhalten

Abstract

The objective of this study was to determine the characteristics of cerebrovascular accidents at time of diagnosis in patients with giant cell arteritis. Retrospective data were collected from 98 patients at a single hospital with giant cell arteritis (according to the American College of Rheumatology classification criteria) diagnosed between October 1999 and January 2012. Cerebrovascular accident was found at initial presentation in 6 patients (6.1 %, 95 % CIs 2.3–12.9). Most of them had other symptoms of giant cell arteritis when the disease began. Signs reflecting the involvement of vertebro-basilar territory were present in 3 cases. No other case of cerebrovascular accident was described during the follow-up of patient; particularly no case of cerebrovascular accident occurred once corticosteroid therapy for the treatment of giant cell arteritis had been initiated. No differences in the epidemiologic, clinical and laboratory features at the time of diagnosis between patients who had cerebrovascular accidents and the rest of the giant cell arteritis patients were observed. Prognosis was good in our survey. However, there was no case of bilateral vertebral artery occlusion, a condition associated with poor prognosis. The present study confirms that cerebrovascular accidents may be the initial manifestation of giant cell arteritis, an argument in favor of a direct effect of the vasculitis in the development of cerebrovascular accidents rather than a complication of the corticosteroid therapy. The diagnosis of giant cell arteritis should always be considered in an elderly patient with stroke and an unexplained elevation of inflammatory biomarkers.
Literatur
1.
Zurück zum Zitat Salvarani C, Cantini F, Boiardi L, Hunder GG (2002) Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 2:261–271CrossRef Salvarani C, Cantini F, Boiardi L, Hunder GG (2002) Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 2:261–271CrossRef
2.
Zurück zum Zitat Weyand CM, Goronzy JJ (2003) Giant-cell arteritis and polymyalgia rheumatica. Ann Intern Med 139:505–515PubMedCrossRef Weyand CM, Goronzy JJ (2003) Giant-cell arteritis and polymyalgia rheumatica. Ann Intern Med 139:505–515PubMedCrossRef
3.
Zurück zum Zitat Solans-Laqué R, Bosch-Gil JA, Molina-Catenario CA, Ortega-Aznar A, Alvarez-Sabin J, Vilardell-Torres M (2008) Stroke and multi-infarct dementia as presenting symptoms of giant cell arteritis. Report of 7 cases and review of the literature. Medicine 87:335–344PubMedCrossRef Solans-Laqué R, Bosch-Gil JA, Molina-Catenario CA, Ortega-Aznar A, Alvarez-Sabin J, Vilardell-Torres M (2008) Stroke and multi-infarct dementia as presenting symptoms of giant cell arteritis. Report of 7 cases and review of the literature. Medicine 87:335–344PubMedCrossRef
4.
Zurück zum Zitat Gonzales-Gay MA, Vazquez-Rodriguez TR, Gomez-Acebo I, Pego-Reigosa R, Lopez-Dias MJ, Vazquez-Trinanes MC et al (2009) Strokes at time of disease diagnosis in a series of 287 patients with biopsy-proven giant-cell arteritis. Medicine 88:227–235CrossRef Gonzales-Gay MA, Vazquez-Rodriguez TR, Gomez-Acebo I, Pego-Reigosa R, Lopez-Dias MJ, Vazquez-Trinanes MC et al (2009) Strokes at time of disease diagnosis in a series of 287 patients with biopsy-proven giant-cell arteritis. Medicine 88:227–235CrossRef
5.
Zurück zum Zitat Gonzales-Gay MA, Blanco R, Rodriguez-Valverde V, Martinez-Taboada VM, Delgado-Rodriguez M, Figueroa M et al (1998) Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment. Arthritis Rheum 41:1497–1504CrossRef Gonzales-Gay MA, Blanco R, Rodriguez-Valverde V, Martinez-Taboada VM, Delgado-Rodriguez M, Figueroa M et al (1998) Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment. Arthritis Rheum 41:1497–1504CrossRef
6.
Zurück zum Zitat Pego-Reigosa R, Garcia-Porrua C, Pineiro A, Dierssen T, Llorca J, Gonzales-Gay MA (2004) Predictors of cerebrovascular accidents in giant cell arteritis in a defined population. Clin Exp Rheumatol 22(Suppl 36):S13–S17PubMed Pego-Reigosa R, Garcia-Porrua C, Pineiro A, Dierssen T, Llorca J, Gonzales-Gay MA (2004) Predictors of cerebrovascular accidents in giant cell arteritis in a defined population. Clin Exp Rheumatol 22(Suppl 36):S13–S17PubMed
7.
Zurück zum Zitat Hunder CG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH et al (1990) The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33:1122–1128PubMedCrossRef Hunder CG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH et al (1990) The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33:1122–1128PubMedCrossRef
8.
Zurück zum Zitat Caselli RJ, Hunder GG, Whisnant JP (1988) Neurologic disease in biopsy-proven giant-cell (temporal) arteritis. Neurology 38:352–359PubMedCrossRef Caselli RJ, Hunder GG, Whisnant JP (1988) Neurologic disease in biopsy-proven giant-cell (temporal) arteritis. Neurology 38:352–359PubMedCrossRef
9.
Zurück zum Zitat Nesher G, Berkun Y, Mates M, Baras M, Rubinow A, Sonnenblick M (2004) Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis Rheum 50:1332–1337PubMedCrossRef Nesher G, Berkun Y, Mates M, Baras M, Rubinow A, Sonnenblick M (2004) Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis Rheum 50:1332–1337PubMedCrossRef
10.
Zurück zum Zitat Wiszniewska M, Devuyst G, Bogousslavsky J (2007) Giant cell arteritis as a cause of first ever-stroke. Cerebrovasc Dis 24:226–230PubMedCrossRef Wiszniewska M, Devuyst G, Bogousslavsky J (2007) Giant cell arteritis as a cause of first ever-stroke. Cerebrovasc Dis 24:226–230PubMedCrossRef
11.
Zurück zum Zitat Salvarani C, Della Bella C, Cimino L, Macchioni P, Formisano D, Bajocchi G et al (2009) Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis. Rheumatology (Oxford) 48:250–253CrossRef Salvarani C, Della Bella C, Cimino L, Macchioni P, Formisano D, Bajocchi G et al (2009) Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis. Rheumatology (Oxford) 48:250–253CrossRef
12.
Zurück zum Zitat Fitzgerald AJ, Ironside JW, Summers DM, Dennis MS, McRorie ER (2010) Two cases of recurrent stroke in treated giant cell arteritis: diagnostic and therapeutic dilemmas. J Clin Rheumatol 16:225–228PubMedCrossRef Fitzgerald AJ, Ironside JW, Summers DM, Dennis MS, McRorie ER (2010) Two cases of recurrent stroke in treated giant cell arteritis: diagnostic and therapeutic dilemmas. J Clin Rheumatol 16:225–228PubMedCrossRef
13.
Zurück zum Zitat Collazos J, Garcia-Monco C, Martin A, Rodriguez J, Angeles Gomez M (1994) Multiple strokes after initiation of steroid therapy in giant cell arteritis. Postgrad Med J 70:228–230PubMedCrossRef Collazos J, Garcia-Monco C, Martin A, Rodriguez J, Angeles Gomez M (1994) Multiple strokes after initiation of steroid therapy in giant cell arteritis. Postgrad Med J 70:228–230PubMedCrossRef
14.
Zurück zum Zitat Berger CT, Wolbers M, Meyer P, Daikeler T, Hess C (2009) High incidence of severe ischaemic complications in patients with giant cell arteritis irrespective of platelet count and size, and platelet inhibition. Rheumatology (Oxford) 48:258–261CrossRef Berger CT, Wolbers M, Meyer P, Daikeler T, Hess C (2009) High incidence of severe ischaemic complications in patients with giant cell arteritis irrespective of platelet count and size, and platelet inhibition. Rheumatology (Oxford) 48:258–261CrossRef
15.
Zurück zum Zitat Howard GF III, Ho SU, Kim KS, Wallach J (1984) Bilateral carotid artery occlusion resulting from giant-cell arteritis. Ann Neurol 15:204–207PubMedCrossRef Howard GF III, Ho SU, Kim KS, Wallach J (1984) Bilateral carotid artery occlusion resulting from giant-cell arteritis. Ann Neurol 15:204–207PubMedCrossRef
16.
Zurück zum Zitat Salvarani C, Giannini C, Miller DV, Hunder G (2006) Giant cell arteritis: involvement of intracranial arteries. Arthritis Rheum 55:985–989PubMedCrossRef Salvarani C, Giannini C, Miller DV, Hunder G (2006) Giant cell arteritis: involvement of intracranial arteries. Arthritis Rheum 55:985–989PubMedCrossRef
17.
Zurück zum Zitat Kumar A, Costa DD (2007) Insidious posterior circulation stroke with rapid deterioration due to vertebral giant cell arteritis. Age Aging 36:695–697CrossRef Kumar A, Costa DD (2007) Insidious posterior circulation stroke with rapid deterioration due to vertebral giant cell arteritis. Age Aging 36:695–697CrossRef
18.
Zurück zum Zitat Ronthal M, Gonzales RG, Smith RN, Frosh MP (2003) Case records of the Massachusetts General Hospital. Case 21–2003. A 72-year-old man with repetitive strokes in the posterior circulation. N Engl J Med 349:170–180PubMedCrossRef Ronthal M, Gonzales RG, Smith RN, Frosh MP (2003) Case records of the Massachusetts General Hospital. Case 21–2003. A 72-year-old man with repetitive strokes in the posterior circulation. N Engl J Med 349:170–180PubMedCrossRef
19.
Zurück zum Zitat Sheehan MM, Keohane C, Twomey C (1993) Fatal vertebral giant cell arteritis. J Clin Pathol 46:1129–1131PubMedCrossRef Sheehan MM, Keohane C, Twomey C (1993) Fatal vertebral giant cell arteritis. J Clin Pathol 46:1129–1131PubMedCrossRef
20.
Zurück zum Zitat Richard S, Anxionnat R, Delaunay C, Ducrocq X (2009) Giant cell arteritis revealed by vertebrobasilar insufficiency. J Rheumatol 36:457–458PubMedCrossRef Richard S, Anxionnat R, Delaunay C, Ducrocq X (2009) Giant cell arteritis revealed by vertebrobasilar insufficiency. J Rheumatol 36:457–458PubMedCrossRef
21.
Zurück zum Zitat Gonzalez-Gay MA, Pineiro A, Gomez-Gigirey A et al (2004) Influence of traditional risk factors of atherosclerosis in the development of severe ischemic complications in giant cell arteritis. Medicine (Baltimore) 83:342–347CrossRef Gonzalez-Gay MA, Pineiro A, Gomez-Gigirey A et al (2004) Influence of traditional risk factors of atherosclerosis in the development of severe ischemic complications in giant cell arteritis. Medicine (Baltimore) 83:342–347CrossRef
22.
Zurück zum Zitat Cid MC, Font C, Oristrell J et al (1998) Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis. Arthritis Rheum 41:26–32PubMedCrossRef Cid MC, Font C, Oristrell J et al (1998) Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis. Arthritis Rheum 41:26–32PubMedCrossRef
23.
Zurück zum Zitat Ruegg S, Engelter S, Jeanneret C et al (2003) Bilateral vertebral artery occlusion resulting from giant cell arteritis: report of 3 cases and review of the literature. Medicine 82:1–12PubMedCrossRef Ruegg S, Engelter S, Jeanneret C et al (2003) Bilateral vertebral artery occlusion resulting from giant cell arteritis: report of 3 cases and review of the literature. Medicine 82:1–12PubMedCrossRef
24.
Zurück zum Zitat Boettinger MR, Sebastian SR, Gamulescu MAR, Grauer O, Ritzka M, Schuierer GR et al (2009) Bilateral vertebral artery occlusion with retrograde basilary flow in three cases of giant cell arteritis. BMJ Case Rep. doi:10.1136/BCE.07.2008.0488 Boettinger MR, Sebastian SR, Gamulescu MAR, Grauer O, Ritzka M, Schuierer GR et al (2009) Bilateral vertebral artery occlusion with retrograde basilary flow in three cases of giant cell arteritis. BMJ Case Rep. doi:10.​1136/​BCE.​07.​2008.​0488
25.
Zurück zum Zitat Ahdad R, Thabuy F, Menager de Froberville E, Brugieres P, Hosseini H (2008) Reversible vertebral artery stenosis following corticotherapy in giant cell arteritis. Eur Neurol 59:331 Ahdad R, Thabuy F, Menager de Froberville E, Brugieres P, Hosseini H (2008) Reversible vertebral artery stenosis following corticotherapy in giant cell arteritis. Eur Neurol 59:331
26.
Zurück zum Zitat Takekawa H, Daimon Y, Takashima R, Aiba S, Tanaka H, Hirata K (2008) Giant cell arteritis associated with lesion of the internal carotid artery: assessment of response to steroid therapy by magnetic resonance angiography. Intern Med 47:1285–1286PubMedCrossRef Takekawa H, Daimon Y, Takashima R, Aiba S, Tanaka H, Hirata K (2008) Giant cell arteritis associated with lesion of the internal carotid artery: assessment of response to steroid therapy by magnetic resonance angiography. Intern Med 47:1285–1286PubMedCrossRef
27.
Zurück zum Zitat Lee MS, Smith SD, Galor A, Hoffman G (2006) Antiplatelet and anticoagulant therapy in patients with giant cell arteritis. Arthritis Rheum 54:3306–3309PubMedCrossRef Lee MS, Smith SD, Galor A, Hoffman G (2006) Antiplatelet and anticoagulant therapy in patients with giant cell arteritis. Arthritis Rheum 54:3306–3309PubMedCrossRef
28.
Zurück zum Zitat Garcia–Garcia J, Ayo-Martin O, Argandona-Palacios L, Segura T (2011) Vertebral artery halo sign in patients with stroke: a key clue for the prompt diagnosis of giant cell arteritis. Stroke 42:3287–3290PubMedCrossRef Garcia–Garcia J, Ayo-Martin O, Argandona-Palacios L, Segura T (2011) Vertebral artery halo sign in patients with stroke: a key clue for the prompt diagnosis of giant cell arteritis. Stroke 42:3287–3290PubMedCrossRef
Metadaten
Titel
Characteristics of cerebrovascular accidents at time of diagnosis in a series of 98 patients with giant cell arteritis
verfasst von
Thierry Zenone
Marie Puget
Publikationsdatum
01.12.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 12/2013
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-013-2814-0

Weitere Artikel der Ausgabe 12/2013

Rheumatology International 12/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.